Your browser doesn't support javascript.
loading
Intermittent theta-burst stimulation for upper-limb dysfunction and spasticity in spinal cord injury: a single-blind randomized feasibility study.
Gharooni, Aref-Ali; Nair, Krishnan Padmakumari Sivaraman; Hawkins, Debby; Scivill, Ian; Hind, Daniel; Hariharan, Ram.
Afiliação
  • Gharooni AA; Princess Royal Spinal Injuries Centre, Sheffield Teaching Hospitals, Sheffield, UK.
  • Nair KPS; Clinical Trials Research Unit, University of Sheffield, Regent Court, 30 Regent Court, Sheffield, S1 4DA, UK.
  • Hawkins D; Princess Royal Spinal Injuries Centre, Sheffield Teaching Hospitals, Sheffield, UK.
  • Scivill I; Princess Royal Spinal Injuries Centre, Sheffield Teaching Hospitals, Sheffield, UK.
  • Hind D; Princess Royal Spinal Injuries Centre, Sheffield Teaching Hospitals, Sheffield, UK.
  • Hariharan R; Clinical Trials Research Unit, University of Sheffield, Regent Court, 30 Regent Court, Sheffield, S1 4DA, UK.
Spinal Cord ; 56(8): 762-768, 2018 08.
Article em En | MEDLINE | ID: mdl-29895874
STUDY DESIGN: Single-blind, sham-controlled, crossover randomized feasibility study OBJECTIVES: (1) Assess the feasibility of a full-scale trial of intermittent theta-burst stimulation (iTBS) for upper-limb sensorimotor dysfunction following spinal cord injury (SCI). (2) Determine the safety and tolerability of iTBS over primary motor cortex on upper-limb function in people with spinal cord injury (SCI). SETTING: Large Tertiary Spinal Injuries Centre METHODS: Participants with incomplete SCI, suffering with upper-limb spasticity were recruited and randomized to receive active/sham iTBS over the hand representation of the primary motor cortex. The intervention was delivered in 10 sessions over a 2-week period, followed by a 2-week washout, before being crossed over to receive the alternative intervention for the same number of sessions. Feasibility was assessed by pre-specified criteria which included recruitment rate of 3 participants per month, 10 completed interventions and 10 complete data sets for 15 recruited participants with no serious adverse events. Secondary outcomes included preliminary data collection for spasticity, pain and sensorimotor function. RESULTS: Twelve participants were recruited over 10 weeks (i.e., 4.8 per month), with 11 randomized and 10 completing the intervention protocol with no serious adverse events. Eight complete data sets were obtained as two participants failed to attend follow-up. Data from 10 participants were analyzed, with one early dropout due to an unrelated adverse event. CONCLUSIONS: It is safe and feasible to conduct a full-scale trial. Whilst iTBS has shown promising results, further research optimizing the intervention is required to improve anticipated clinical efficacy.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Traumatismos da Medula Espinal / Distúrbios Somatossensoriais / Extremidade Superior / Estimulação Magnética Transcraniana / Transtornos dos Movimentos / Espasticidade Muscular Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Traumatismos da Medula Espinal / Distúrbios Somatossensoriais / Extremidade Superior / Estimulação Magnética Transcraniana / Transtornos dos Movimentos / Espasticidade Muscular Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article